Guidelines: Intitut National du Cancer Guidelines (Luxembourg): Difference between revisions
m (Update categories.) |
|||
| Line 70: | Line 70: | ||
<span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span> | <span style="display:none">hasCancerType::C81-C96: Cancers of the blood and immune system</span> | ||
<span style="display:none">hasCancerType::C60-C63: Male genitalia cancer</span> | <span style="display:none">hasCancerType::C60-C63: Male genitalia cancer</span> | ||
<span style="display:none">isPracticeGuideline</span> | |||
Revision as of 16:43, 4 December 2025
Go back to Luxembourg page
Primary purpose: To provide recommendations for the treatment of various types of cancers.
Sponsor, manager or home institution: Intitut National du Cancer; Conseil Scientifique Domaine de la Santé.
Type of information: Recommendations, treatments, supportive care and follow up of colorectal cancer, gynecological cancer, breast cancer, pancreatic cancer, cutaneous malignant melanomas, hematological cancers, brain and central nervous system cancer. Click here to learn more.
Cancer areas of interest: C15-C26: Digestive system cancers; C30-C39: Lung/chest cancers; C43-C44: Skin cancers/melanoma; C50: Breast cancer; C51-C58: Female genitalia cancer; C69-C72: Eye and brain cancer; C81-C96: Cancers of the blood and immune system; C60-C63: Male genitalia cancer. Click here to learn more.
Access to information: Click here to access.